Access cutting-edge chronic pancreatitis treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access chronic pancreatitis specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic pancreatitis treatment provided free
The purpose of this study is to evaluate efficacy of pioglitazone (PIO) versus empagliflozin (EMPA) to improve glycemic control in people with Chronic Pancreatitis (CP) or Recurrent Acute Pancreatitis (RAP) associated with Diabetes Mellitus (DM). To evaluate mixed meal response in PIO versus EMPA group to better understand physiology of both therapies in CP-DM.
Sponsor: Mayo Clinic
Check if you qualify for this chronic pancreatitis clinical trial in Pittsburgh, PA
If you're searching for chronic pancreatitis treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic pancreatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.